Circulomics Awarded $1.5M Phase II SBIR to Develop Multiplex microRNA Assay
May 13, 2015 09:17 ET
|
Circulomics
BALTIMORE, MD--(Marketwired - May 13, 2015) - Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) - National...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
November 17, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
November 03, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...
DiamiR Announces Grant From The Michael J. Fox Foundation for Parkinson's Research to Advance Assessment of Brain-Enriched microRNA Biomarkers in Plasma
July 14, 2014 11:00 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 14, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
DiamiR Announces Oral Presentation at the 2014 Alzheimer's Association International Conference
July 10, 2014 08:02 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 10, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
Circulomics Awarded Phase I SBIR to Develop Nanobind DNA Extraction Technology
April 30, 2014 10:12 ET
|
Circulomics
BALTIMORE, MD--(Marketwired - April 30, 2014) -
Circulomics Inc has been awarded a Phase I Small Business Innovative Research (SBIR) grant by the National...
DiamiR Announces Poster Presentation on Detection and Differentiation of Neurodegenerative Diseases at the Biomarkers & Diagnostics World Congress 2014
April 28, 2014 08:00 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - April 28, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...
DiamiR Granted Key US Patent for the Use of Circulating Brain-Enriched microRNAs for Early Detection of Neurodegeneration
February 12, 2014 06:02 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - February 12, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...
DiamiR Reports Validation of Two Families of Brain-Enriched microRNAs as Highly Promising Blood-Based Biomarkers of Mild Cognitive Impairment
January 02, 2014 04:00 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - January 02, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...
Circulomics Awarded Nearly $1M to Develop Multiplex MicroRNA Assay
December 10, 2012 09:21 ET
|
Circulomics Inc
BALTIMORE, MD --(Marketwire - December 10, 2012) -
Circulomics Inc has been awarded two Small Business Innovative Research (SBIR) Phase I awards, totaling $800k...